BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #1870Drug Manufacturers - Specialty & Generic
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–

SUPN Stock News

Headlines matching Supernus or the SUPN ticker, most recent first.

  • Supernus Pharmaceuticals: Supernus Pharmaceuticals, Inc. - Anticipated Adjustment Option Symbol: SUPN New Symbol: SUPN1OCC · 17 Sep 2026 · Direct mention
  • TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $65Market news · 4 Aug 2026 · Direct mention
  • Earnings Flash (SUPN) Supernus Pharmaceuticals Posts Q2 Net Loss $1.01 a Share, Vs. FactSet Est of $0.04 EPS NegativeMT Newswires · 3 Aug 2026 · Direct mention
  • Earnings Flash (SUPN) Supernus Pharmaceuticals, Inc. Reports Q2 Revenue $219.1M, Vs. FactSet Est of $205.3MMT Newswires · 3 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Raises Target Price to $67 PositiveMarket news · 9 Jul 2026 · Direct mention
  • Piper Sandler Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $66Market news · 27 Jul 2026 · Direct mention
  • BofA Securities Initiates Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Announces Target Price $63Market news · 13 Jul 2026 · Direct mention
  • Stifel Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $55Market news · 7 May 2026 · Direct mention
  • Piper Sandler Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Raises Target Price to $66 PositiveMarket news · 13 Apr 2026 · Direct mention
  • TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Raises Target Price to $65 PositiveMarket news · 25 Feb 2026 · Direct mention
  • BofA Securities Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $65Market news · 25 Feb 2026 · Direct mention
  • Piper Sandler Maintains Supernus(SUPN.US) With Buy Rating, Cuts Target Price to $47 NegativeMarket news · 5 Nov 2026 · Direct mention
  • Stifel Maintains Supernus(SUPN.US) With Hold Rating, Cuts Target Price to $37 NegativeMarket news · 5 Nov 2026 · Direct mention
  • Cantor Fitzgerald Maintains Supernus(SUPN.US) With Buy Rating, Raises Target Price to $87 PositiveMarket news · 5 Nov 2026 · Direct mention
  • News On Indivior Pharmaceuticals Inc. (INDV) Now Under SUPNDow Jones · 4 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SUPN.

Sign in to join the discussion.

Scroll to Top